Assessment of the dynamics of specialists’ knowledge on chronic obstructive pulmonary disease during the professional development cycle

   Relevance. Chronic obstructive pulmonary disease (COPD) is one of the most common causes of morbidity and mortality and, as a result, one of the most important health problems. In the coming decades, this disease will continue to be one of the leading causes of disability and mortality. This paper presents the results of the first and second stages of testing students of advanced training courses (ATs) on the basis of the Kazan State Medical Academy, a Branch Campus of the Russian Medical Academy of Continuous Professional Education. An assessment of their knowledge in the dynamics of the etiopathogenesis, diagnosis and pharmacotherapy of COPD was carried out.

   Objective. To assess the level of knowledge of physician on the etiopathogenesis, diagnosis and therapy of COPD and to determine the effectiveness of AT courses by comparing the results of a two-stage questionnaire of students before and after completing the courses.

   Methods. The article presents the results of the statistical analysis of two stages of testing of physicians of the Republic of Mari El according to the questionnaire of the ASCO-III study (full name of the project — Assessment of Senior Medical Students in the Field of COPD) to assess the level of basic knowledge on the issues of etiopathogenesis, diagnosis and treatment of COPD.

   Results. Thirty-seven physicians participated in the survey. The students showed significant positive results: the LCA (average level of completeness of the answer to the question) in the 1st stage was 60.7 %, in the second — 85.8 % (p < 0.001). The most difficult question was the choice of drugs for antibacterial therapy during exacerbations. So, in the 18^th question, the LCA in the 1st stage was equal to 8.1 %, and at the end of the courses — 56.8 %. In the 19^th issue, the LCA improved from 13.5 % to 70.3 %.

   Conclusions. The results of the study indicate a positive trend in the knowledge of doctors on COPD issues and demonstrate the high effectiveness and importance of "high-quality" AT courses.

1. Russian Respiratory Society. Chronic Obstructive Pulmonary Disease. Clinical Recommendations. 2018. Russian Respiratory Society. (In Russ.)] file:///d:/Users/user/Down-loads/%D0%9A%D0%A0603.pdf

2. World Health Organization. Evidence-informed policy-making. 2016. Available from: http://www.who.int/evidence

3. Bontsevich RA, Filinichenko TS, Vovk YR, et al. Comparative assessment of physicians’ and senior medical students’ basic knowledge in treatment of chronic obstructive pulmonary disease. Research Results in Pharmacology. 2019;5(1):67-75. doi: 10.3897/rrpharmacology.4.34072.

4. Bontsevich R, Shershneva A, Vovk Ya, et al. Chronic obstructive pulmonary disease: the assessment of a therapist’s knowledge. The results of the ASCO-II study. Vrach. 2020;31(7):68-74. (In Russ.) doi: 10.29296/25877305-2020-07-13.

5. Bontsevich RA, Adonina AV, Vovk YR et al. Management of Chronic Obstructive Pulmonary Disease. Archives of Razi Institute. 2022;77(1):439-447. doi: 10.22092/ARI.2021.356613.1882.

6. Singh D, Agusti A, Anzueto A, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019. Eur Respir J. 2019 May 18;53(5):1900164. https://doi.org/10.1183/13993003.00164-2019.

7. Protasov AD, Kostinov MP, Zhestkov AV, et al. Choice of optimal vaccination tactics against pneumococcal infection from immunological and clinical standpoints in patients with chronic obstructive pulmonary disease. Therapeutic Archive. 2016;88(5):62-69. (In Russ.) doi: 10.17116/terarkh201688562-69.

8. Chuchalin AG, Avdeev SN, Aisanov ZR, et al. Federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease. PULMONOLOGIYA. 2022;32(3):356-392. (In Russ.) doi: 10.18093/0869-0189-2022-32-3-356-392.

9. Venkatesan P. GOLD COPD report: 2024 update. Lancet Respir Med. 2024 Jan;12(1):15-16. doi: 10.1016/S2213-2600(23)00461-7.

10. Aysanov ZR, Chernyak AV, Kalmanova EN. Spirometry for diagnosis and therapeutic efficacy evaluation in chronic obstructive pulmonary disease in primary care. PULMONOLOGIYA. 2014;(5):101-110. (In Russ.) doi: 10.18093/0869-0189-2014-0-5-101-110.

11. Maksimov ML, Bontsevich RA, Shikaleva AA. Modern pharmacotherapy approaches to treating chronic obstructive pulmonary disease. Part 1: Main and additional groups of drugs used in COPD therapy. Therapist. 2024;(10):43-61. (In Russ.) doi: 10.33920/MED-12-2410-04.

12. Maksimov ML, Bontsevich RA, Shikaleva AA. Treatment of exacerbations of chronic obstructive pulmonary disease. Therapist. 2024;(12):46-55. (In Russ.) doi: 10.33920/MED-12-2412-06.

13. Avdeev SN, Leshchenko IV, Aisanov ZR. New concept and algorithm for the management of patients with chronic obstructive pulmonary disease. PULMONOLOGIYA. 2023;33(5):587-594. (In Russ.) doi: 10.18093/0869-0189-2023-33-5-587-594.

14. O'Donnell DE, Parker CM. COPD exacerbations. 3: Pathophysiology. Thorax. 2006 Apr;61(4):354-61. doi: 10.1136/thx.2005.041830.

15. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002 Oct;57(10):847-52. doi: 10.1136/thorax.57.10.847.

16. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1418-22. doi: 10.1164/ajrccm.157.5.9709032.

17. Miravitlles M, Murio C, Guerrero T, Gisbert R; DAFNE Study Group. Decisiones sobre Antibioticoterapia y Farmacoeconomía en la EPOC. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest. 2002 May;121(5):1449-55. doi: 10.1378/chest.121.5.1449.

18. Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J. 2007 Jun;29(6):1224-38. doi: 10.1183/09031936.00109906. Erratum in: Eur Respir J. 2007 Aug; 30 (2):401.

19. Seneff MG, Wagner DP, Wagner RP, et al. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA. 1995 Dec 20;274(23):1852-7.

20. Bontsevich RA. Educational pharmacoepidemiology and "Real-World Knowledge". Real-World Data & Evidence. 2024;4(4):44-52. (In Russ.) doi: 10.37489/2782-3784-myrwd-062. EDN: DVBLIV.